Trial Profile
A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Cilnidipine/valsartan (Primary) ; Cilnidipine; Valsartan
- Indications Hypertension
- Focus Pharmacokinetics
- Acronyms IDCV
- Sponsors Ildong Pharmaceutical
- 12 Jan 2016 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov record.
- 24 Jan 2015 New trial record